AngioDynamics Extraordinary Items from 2010 to 2024

ANGO Stock  USD 6.99  0.15  2.10%   
AngioDynamics Extraordinary Items yearly trend continues to be very stable with very little volatility. Extraordinary Items is likely to drop to about 42 M. During the period from 2010 to 2024, AngioDynamics Extraordinary Items quarterly data regression pattern had sample variance of 909 T and median of  29,962,000. View All Fundamentals
 
Extraordinary Items  
First Reported
2001-08-31
Previous Quarter
5.4 M
Current Value
72.5 M
Quarterly Volatility
8.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AngioDynamics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AngioDynamics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.5 M, Interest Expense of 1.7 M or Total Revenue of 246.7 M, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.0 or PTB Ratio of 1.29. AngioDynamics financial statements analysis is a perfect complement when working with AngioDynamics Valuation or Volatility modules.
  
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.

Latest AngioDynamics' Extraordinary Items Growth Pattern

Below is the plot of the Extraordinary Items of AngioDynamics over the last few years. It is AngioDynamics' Extraordinary Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AngioDynamics' overall financial position and show how it may be relating to other accounts over time.
Extraordinary Items10 Years Trend
Slightly volatile
   Extraordinary Items   
       Timeline  

AngioDynamics Extraordinary Items Regression Statistics

Arithmetic Mean40,143,811
Geometric Mean28,801,965
Coefficient Of Variation75.10
Mean Deviation27,569,132
Median29,962,000
Standard Deviation30,149,149
Sample Variance909T
Range71.3M
R-Value0.82
Mean Square Error324.2T
R-Squared0.67
Significance0.0002
Slope5,513,097
Total Sum of Squares12725.6T

AngioDynamics Extraordinary Items History

202442 M
202383.4 M
201872.5 M
201730 M

About AngioDynamics Financial Statements

AngioDynamics investors utilize fundamental indicators, such as Extraordinary Items, to predict how AngioDynamics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Extraordinary Items83.4 M42 M

Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

Moving together with AngioDynamics Stock

  0.61GH Guardant Health Buyout TrendPairCorr

Moving against AngioDynamics Stock

  0.64VMD Viemed HealthcarePairCorr
  0.6CVS CVS Health CorpPairCorr
  0.52BSX Boston Scientific CorpPairCorr
  0.51VNRX VolitionrxPairCorr
  0.49DRIO DarioHealth CorpPairCorr
The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out the analysis of AngioDynamics Correlation against competitors.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.80)
Revenue Per Share
7.249
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.06)
Return On Equity
(0.78)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.